Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reductive Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic route for Bazedoxifene intermediates eliminates hazardous reagents, offering cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN114989067B reveals a high-yield synthetic route for Paritaprevir intermediates, offering cost reduction and scalable manufacturing for global supply chains.
Novel six-step synthesis route for complex azepine intermediates offering high purity, scalable manufacturing, and significant cost reduction for pharmaceutical applications.
Patent CN120554282A reveals organic acid purification for Revefenacin intermediates. Achieve high purity and scalable manufacturing for respiratory drug supply chains.
Advanced stereoselective preparation of substituted piperidine derivatives via patent CN1038932C. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Discover the patented bimetallic catalytic route for 5-[(phenylamino)methyl]-2-furanmethanol. Enhance supply chain reliability and reduce manufacturing costs with this green technology.
Patent CN101712623B details a cost-effective Pd/C catalyzed route for Methoxyphenamine Hydrochloride, offering >99% purity and superior supply chain reliability.
Patent CN101712623A details a high-yield Pd/C catalyzed route for Methoxyphenamine Hydrochloride, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN101747206A reveals a high-yield reductive amination route for N,N-dibenzyl-ethylenediamin diacetate, offering significant cost reduction in API manufacturing and superior purity profiles.
Novel reductive amination route for Levobupivacaine HCL ensures mild conditions and high yield. Reliable supply chain partner for pharmaceutical intermediates.
Novel synthesis of 1-substituted phenyl-4-substituted phenyl-5-(2-hydroxyl substituted benzyl) amino-1,2,3-triazole compounds offering high yield and green chemistry benefits for pharmaceutical manufacturing.
Patent CN1025852C details a novel route for quinolone intermediates. Discover cost-effective synthesis and scalable manufacturing solutions for complex diazabicyclic compounds.
Patent CN88101658A reveals a Ni-Ru-M catalyst for high-selectivity reductive amination, offering cost-effective amine production and supply chain stability.
Patent CN103665032B reveals a high-yield Glufosinate ammonium process. Discover cost reduction in herbicide manufacturing and scalable supply chain solutions.
Patent CN110156816B details a novel synthesis route for tetrahydropyrazolopiperazine compounds, offering improved yield and synergistic anticancer potential for pharmaceutical supply chains.
Novel nitration-bromination-deamination route for 2-bromo-3-fluorobenzoic acid. Cost-effective, scalable pharma intermediate manufacturing with high purity.
Patent CN116514703A reveals a continuous fixed-bed hydrogenation method for N-Boc-4-dimethylaminopiperidone, offering high purity and reduced waste for pharmaceutical supply chains.
Novel one-pot method for lapatinib improves yield and purity, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel leucine dehydrogenase mutants enable high-efficiency synthesis of unnatural amino acids with improved stability and conversion rates for scalable pharmaceutical manufacturing.
Patent CN112939971A discloses pyrido[2,3-d]pyrimidin-7-one derivatives as potent NEDD8 inhibitors, offering new routes for cost-effective API manufacturing and supply chain stability.